Aims & Scope
In recent years, a breakthrough has occurred in our understanding of the
molecular pathomechanisms of human diseases, whereby most of our diseases are related to
intra- and
intercellular communication disorders. The concept of signal transduction
therapy has become the
forefront of modern drug research, and a
multidisciplinary approach is being used to identify and treat signaling
disorders.
The journal publishes timely in-depth/mini-reviews, research articles, and drug clinical
trial studies in the field of signal transduction therapy. Thematic issues are
also published to cover selected areas of signal transduction therapy. Coverage
of the field includes genomics, proteomics, medicinal chemistry and the
relevant diseases involved in signaling, e.g., cancer and
neurodegenerative and inflammatory diseases. Current Signal
Transduction Therapy is an essential journal for all researchers involved in
drug design and discovery.
Current Signal Transduction Therapy is an international, peer-reviewed journal on
all aspects of signal transduction
therapy published quarterly
(print & online) by Bentham Science Publishers.